PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Merck & Co. Inc (6MK.DE)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS58933Y1055
SectorHealthcare
IndustryDrug Manufacturers - General

Highlights

Market Cap€259.14B
EPS (TTM)€4.83
PE Ratio21.16
PEG Ratio0.08
Total Revenue (TTM)€46.52B
Gross Profit (TTM)€35.32B
EBITDA (TTM)€14.10B
Year Range€88.43 - €124.27

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: 6MK.DE vs. ^GSPC

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Merck & Co. Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-15.00%-10.00%-5.00%0.00%5.00%10.00%MayJuneJulyAugustSeptemberOctober
-13.94%
7.48%
6MK.DE (Merck & Co. Inc)
Benchmark (^GSPC)

Returns By Period

Merck & Co. Inc had a return of 6.14% year-to-date (YTD) and 8.98% in the last 12 months. Over the past 10 years, Merck & Co. Inc had an annualized return of 12.61%, outperforming the S&P 500 benchmark which had an annualized return of 11.26%.


PeriodReturnBenchmark
Year-To-Date6.14%19.70%
1 month-4.67%1.08%
6 months-13.94%9.56%
1 year8.98%34.99%
5 years (annualized)10.59%14.15%
10 years (annualized)12.61%11.26%

Monthly Returns

The table below presents the monthly returns of 6MK.DE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202414.14%5.53%3.76%-0.16%-4.76%4.63%-12.44%0.95%-4.17%6.14%
2023-5.67%2.55%-2.46%7.19%-0.96%2.28%-8.38%5.82%-3.23%-1.64%-3.12%6.31%-2.63%
20226.34%-6.86%11.38%12.86%1.79%2.97%-0.00%-1.95%4.81%14.83%2.15%0.32%57.81%
2021-4.50%-5.03%10.14%-5.64%0.47%11.47%-0.90%-0.20%1.81%16.03%-13.55%4.99%11.94%
2020-5.61%-11.37%3.02%4.29%-3.01%-3.06%-0.59%6.21%-1.07%-9.09%4.38%0.70%-15.65%
2019-1.93%9.90%4.69%-5.94%2.68%3.72%2.58%4.64%-1.27%0.00%2.33%4.37%27.91%
20180.63%-6.49%1.10%11.05%3.17%3.65%7.18%4.82%4.70%6.44%6.19%-3.54%44.85%
20171.75%8.02%-3.85%-3.24%1.24%-2.30%-3.70%-2.33%2.54%-12.24%-1.93%3.64%-12.99%
2016-6.15%0.87%1.65%1.95%6.02%2.87%1.57%7.01%0.39%-3.29%8.49%-2.53%19.39%
201513.72%-3.09%3.99%-0.76%1.19%-4.57%3.31%-7.44%-9.28%12.84%2.07%-2.30%7.23%
20148.63%6.20%-1.19%3.70%1.02%0.32%1.64%6.69%3.90%-1.72%5.50%-1.50%37.84%
20133.67%2.06%5.65%6.70%-1.13%1.94%-0.66%-1.93%-0.21%-5.35%10.44%-0.23%21.88%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 6MK.DE is 50, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of 6MK.DE is 5050
6MK.DE (Merck & Co. Inc)
The Sharpe Ratio Rank of 6MK.DE is 5353Sharpe Ratio Rank
The Sortino Ratio Rank of 6MK.DE is 4343Sortino Ratio Rank
The Omega Ratio Rank of 6MK.DE is 4343Omega Ratio Rank
The Calmar Ratio Rank of 6MK.DE is 5959Calmar Ratio Rank
The Martin Ratio Rank of 6MK.DE is 5151Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Merck & Co. Inc (6MK.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


6MK.DE
Sharpe ratio
The chart of Sharpe ratio for 6MK.DE, currently valued at 0.35, compared to the broader market-4.00-2.000.002.000.35
Sortino ratio
The chart of Sortino ratio for 6MK.DE, currently valued at 0.61, compared to the broader market-4.00-2.000.002.004.000.61
Omega ratio
The chart of Omega ratio for 6MK.DE, currently valued at 1.08, compared to the broader market0.501.001.501.08
Calmar ratio
The chart of Calmar ratio for 6MK.DE, currently valued at 0.40, compared to the broader market0.002.004.006.000.40
Martin ratio
The chart of Martin ratio for 6MK.DE, currently valued at 0.93, compared to the broader market-10.000.0010.0020.000.93
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.64, compared to the broader market-4.00-2.000.002.002.64
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.52, compared to the broader market-4.00-2.000.002.004.003.52
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.48, compared to the broader market0.501.001.501.48
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.34, compared to the broader market0.002.004.006.002.34
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 16.17, compared to the broader market-10.000.0010.0020.0016.17

Sharpe Ratio

The current Merck & Co. Inc Sharpe ratio is 0.35. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Merck & Co. Inc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.00MayJuneJulyAugustSeptemberOctober
0.35
2.14
6MK.DE (Merck & Co. Inc)
Benchmark (^GSPC)

Dividends

Dividend History

Merck & Co. Inc granted a 2.76% dividend yield in the last twelve months. The annual payout for that period amounted to €2.82 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend€2.82€2.74€2.67€2.24€2.14€2.02€1.70€1.66€1.67€1.64€1.35€1.30

Dividend yield

2.76%2.79%2.57%3.29%3.37%2.59%2.70%3.68%3.10%3.50%2.96%3.78%

Monthly Dividends

The table displays the monthly dividend distributions for Merck & Co. Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024€0.00€0.00€0.71€0.00€0.00€0.72€0.00€0.00€0.69€0.00€2.12
2023€0.00€0.00€0.68€0.00€0.00€0.67€0.00€0.00€0.69€0.00€0.00€0.70€2.74
2022€0.00€0.00€0.63€0.00€0.00€0.66€0.00€0.00€0.69€0.00€0.00€0.68€2.67
2021€0.00€0.00€0.54€0.00€0.00€0.54€0.00€0.00€0.55€0.00€0.00€0.61€2.24
2020€0.00€0.00€0.55€0.00€0.00€0.54€0.00€0.00€0.51€0.00€0.00€0.54€2.14
2019€0.00€0.00€0.49€0.00€0.00€0.49€0.00€0.00€0.50€0.00€0.00€0.55€2.02
2018€0.00€0.00€0.39€0.00€0.00€0.41€0.00€0.00€0.41€0.00€0.00€0.49€1.70
2017€0.00€0.00€0.44€0.00€0.00€0.42€0.00€0.00€0.39€0.00€0.00€0.41€1.66
2016€0.00€0.00€0.41€0.00€0.00€0.41€0.00€0.00€0.41€0.00€0.00€0.44€1.67
2015€0.00€0.00€0.42€0.00€0.00€0.40€0.00€0.00€0.40€0.00€0.00€0.42€1.64
2014€0.00€0.00€0.32€0.00€0.00€0.32€0.00€0.00€0.34€0.00€0.00€0.36€1.35
2013€0.33€0.00€0.00€0.32€0.00€0.00€0.32€0.00€0.00€0.32€1.30

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%2.8%
Merck & Co. Inc has a dividend yield of 2.76%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%61.9%
Merck & Co. Inc has a payout ratio of 61.85%, which is quite average when compared to the overall market. This suggests that Merck & Co. Inc strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%MayJuneJulyAugustSeptemberOctober
-17.50%
-0.63%
6MK.DE (Merck & Co. Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Merck & Co. Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Merck & Co. Inc was 84.55%, occurring on Oct 10, 2008. Recovery took 1449 trading sessions.

The current Merck & Co. Inc drawdown is 17.50%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-84.55%Dec 20, 20001973Oct 10, 20081449Aug 18, 20143422
-40.25%Apr 14, 1999231Mar 8, 2000147Oct 5, 2000378
-28.99%Mar 7, 2017262Mar 26, 201897Aug 16, 2018359
-24.5%Dec 27, 2019299Mar 3, 2021169Oct 29, 2021468
-23.48%Jul 20, 199859Oct 8, 199855Dec 28, 1998114

Volatility

Volatility Chart

The current Merck & Co. Inc volatility is 6.46%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%MayJuneJulyAugustSeptemberOctober
6.46%
3.28%
6MK.DE (Merck & Co. Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Merck & Co. Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Merck & Co. Inc compared to its peers in the Drug Manufacturers - General industry.


PE Ratio
20.040.060.080.0100.0120.021.2

The chart displays the price to earnings (P/E) ratio for 6MK.DE in comparison to other companies of the Drug Manufacturers - General industry. Currently, 6MK.DE has a PE value of 21.2. This PE value is considered to be low compared to the rest of the industry.

PEG Ratio
10.020.030.00.1

The chart displays the price to earnings to growth (PEG) ratio for 6MK.DE in comparison to other companies of the Drug Manufacturers - General industry. Currently, 6MK.DE has a PEG value of 0.1. This PEG value is considered to be low compared to the rest of the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Merck & Co. Inc.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items